How OHSU's 'SMMART' cancer trial helped guide one patient to unconventional treatments
June 17, 2022
A story features a 29-year-old patient with sarcoma and his experience with the SMMART clinical trial platform, designed to allow researchers to study an individual’s tumor in detail and track how the cells evolve in response to treatment. Lara Davis, M.D., describes how SMMART has benefited this particular patient: “The two medicines [have been] combined in clinical trials for some cancers but haven’t been used for this before. It was a unique combination we came to, based on his exposures, limitations of the medicines we could use for him and the susceptibilities we saw for his tumor."